Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial. (linkinghub.elsevier.com)

Authors: Andemariam B … Abboud MR Journal: The Lancet Published: 2026-10-24 DOI: https://doi.org/10.1016/S0140-6736(26)01480-7